Variant report
Variant | esv3375679 |
---|---|
Chromosome Location | chr10:83202021-83242521 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538669335 | chr10:83204046-83204047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs148798279 | chr10:83204084-83204085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557212129 | chr10:83204088-83204089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs11813825 | chr10:83204099-83204100 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs542949703 | chr10:83204106-83204107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559074673 | chr10:83204188-83204189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548494361 | chr10:83204206-83204207 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528134085 | chr10:83204209-83204210 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183932230 | chr10:83204316-83204317 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565024095 | chr10:83204332-83204333 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544545295 | chr10:83204342-83204343 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188983962 | chr10:83204355-83204356 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554727988 | chr10:83204362-83204363 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs549933622 | chr10:83204373-83204374 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569918380 | chr10:83204409-83204410 | Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs56339756 | chr10:83204426-83204427 | Flanking Active TSS Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs549691456 | chr10:83204436-83204437 | Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs55641847 | chr10:83204452-83204453 | Flanking Active TSS Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs559198105 | chr10:83204458-83204459 | Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528048440 | chr10:83204503-83204504 | Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144885886 | chr10:83204586-83204587 | Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557955975 | chr10:83204637-83204638 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs147935953 | chr10:83204642-83204643 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs537566464 | chr10:83204643-83204644 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141727826 | chr10:83204651-83204652 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147071033 | chr10:83204782-83204783 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs1329190 | chr10:83204861-83204862 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs11815555 | chr10:83204890-83204891 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs200478823 | chr10:83204918-83204919 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570256677 | chr10:83204961-83204962 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs68025171 | chr10:83204965-83204966 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs77178285 | chr10:83204988-83204989 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192954404 | chr10:83204992-83204993 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs537982512 | chr10:83210665-83210666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs197775 | chr10:83210669-83210670 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
36 | rs544741076 | chr10:83210684-83210685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs142306514 | chr10:83210715-83210716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112952160 | chr10:83210725-83210726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs554051757 | chr10:83210742-83210743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576589488 | chr10:83210743-83210744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs533395721 | chr10:83210752-83210753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs140490497 | chr10:83210792-83210793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs73303757 | chr10:83210795-83210796 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs529563845 | chr10:83210830-83210831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs549331401 | chr10:83210872-83210873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs565954463 | chr10:83210880-83210881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs374311757 | chr10:83210890-83210891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs148657329 | chr10:83231847-83231848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs79087185 | chr10:83231900-83231901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs75961686 | chr10:83231901-83231902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Lung cancer | 18438408 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Usher syndrome | 20538994 | CNVD |
Medulloblastoma | 16783165 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Paraganglioma | 17535989 | CNVD |
Submicroscopic aberration syndrome | 21292638 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 18645599 | CNVD |
Polyposis syndrome | 18645599 | CNVD |
Prostate cancer | 17245344 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 22032731 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:83204000-83204400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr10:83204200-83204600 | Active TSS | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr10:83204400-83204600 | Flanking Active TSS | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr10:83204600-83205000 | Active TSS | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr10:83210600-83211000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr10:83231800-83234200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr10:83232200-83233600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
8 | chr10:83232600-83233000 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr10:83232600-83233800 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr10:83233200-83233800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr10:83241800-83242000 | Enhancers | Brain Germinal Matrix | brain |